These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22187891)

  • 1. [Basis of prescribing antipsychotics].
    Sato S
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1036-40. PubMed ID: 22187891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Switching to monotherapy and optimization of drug therapy for long-term hospitalized patients and chronically sick patients].
    Hirao T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1041-7. PubMed ID: 22187892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia.
    Ponto T; Ismail NI; Abdul Majeed AB; Marmaya NH; Zakaria ZA
    Methods Find Exp Clin Pharmacol; 2010; 32(6):427-32. PubMed ID: 20852752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
    Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
    Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is it valid to concurrently use multiple antipsychotics for patients with schizophrenia?].
    Suzuki T; Watanabe K; Yagi G; Kashima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Aug; 25(4):159-68. PubMed ID: 16190364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
    Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
    Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world antipsychotic treatment practices.
    Moore TA; Covell NH; Essock SM; Miller AL
    Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in the treatment of schizophrenia.
    Wolff-Menzler C; Hasan A; Malchow B; Falkai P; Wobrock T
    Pharmacopsychiatry; 2010 Jun; 43(4):122-9. PubMed ID: 20309809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lifelong relapse prevention with antipsychotics in schizophrenia].
    Hasan A; Wobrock T
    Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
    [No Abstract]   [Full Text] [Related]  

  • 18. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
    Snowdon J; Day S; Baker W
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy in schizophrenia.
    Zink M; Englisch S; Meyer-Lindenberg A
    Curr Opin Psychiatry; 2010 Mar; 23(2):103-11. PubMed ID: 20051861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications.
    Sernyak MJ; Rosenheck R
    Adm Policy Ment Health; 2007 Nov; 34(6):540-7. PubMed ID: 17957463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.